ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,546,789, issued on Feb. 10, was assigned to UNIVERSITY OF NEWCASTLE UPON TYNE (Newcastle upon Tyne, Great Britain).
"Detection of pathological protein aggregation" was invented by Marzena Kurzawa-Akanbi (Newcastle upon Tyne, Great Britain) and Christopher Mile Morris (Newcastle upon Tyne, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel methods of identifying, monitoring or determining the risk of developing a protein misfolding neurodegenerative disorder in a subject, particularly an alpha synucleinopathy (including Parkinson's disease and dementia with Lewy bodies) using extracellular vesicle samples. C...